UCB SA

Pharmaceuticals

Company Summary

UCB SA is a biopharmaceutical business that discovers medicines and solutions for people suffering from neurological and immune disorders. The corporation has operations in the United States, Japan, Germany, the rest of Europe, Spain, France, Italy, the United Kingdom, Ireland, China, and Belgium, as well as globally. The company's headquarters are in Brussels, Belgium, where it was formed in 1928.

ESG Rating Overview

Sustainalytics

Overall ESG Rating :

17
Rating Scale
0-10Negligible10-20Low20-30Med30-40High40+Severe
0100E0S9.8G6.8

Refinitiv

Overall ESG Rating :

87
Rating Scale
0-25Poor 25-50Satisfactory 50-75Good75-100Excellent
0100E78S93G87

Overall ESG Rating :

A
Rating Scale
CCCB
Laggard
BBBBBA
Average
AAAAA
Leader

UCB is average among 86 companies in the pharmaceuticals industry.

Temperature Rise :

1.3℃
CLIMATE SCALE
≥ 3.85°CLagging > 2°C - < 3.85°CMisaligned ≤ 2°CAligned